NRX Pharmaceuticals

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NRXP and other ETFs, options, and stocks.

About NRXP

NRX Pharmaceuticals, Inc. is a clinical-stage small molecule pharmaceutical company. It engages in developing of novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases.

CEO

Jonathan C. Javitt

CEOJonathan C. Javitt

Employees

—

Employees—

Headquarters

Wilmington, Delaware

HeadquartersWilmington, Delaware

Founded

2017

Founded2017

Employees

—

Employees—

NRXP Key Statistics

Market cap

33.49M

Market cap33.49M

Price-Earnings ratio

-0.82

Price-Earnings ratio-0.82

Dividend yield

—

Dividend yield—

Average volume

87.64K

Average volume87.64K

High today

$2.07

High today$2.07

Low today

$1.94

Low today$1.94

Open price

$1.95

Open price$1.95

Volume

54.28K

Volume54.28K

52 Week high

$6.01

52 Week high$6.01

52 Week low

$1.10

52 Week low$1.10

NRX Pharmaceuticals

Why Robinhood?

NRX Pharmaceuticals, Inc. is a clinical-stage small molecule pharmaceutical company. It engages in developing of novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. Show more

NRXP Key Statistics

NRX Pharmaceuticals, Inc. is a clinical-stage small molecule pharmaceutical company. It engages in developing of novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases.